Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.63K 9.04K | Sales 2023 | 555 367.75 501.9 | Capitalization | 39.72M 26.32M 35.92M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.9M -21.7M | Net income 2023 | -20M -13.25M -18.09M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.88M 6.66M | Net cash position 2023 | 3.44M 2.28M 3.12M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+28.24% | 48.16B | |
-0.23% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.98% | 25.59B | |
-22.68% | 18.96B | |
+8.57% | 12.92B | |
+29.89% | 12.03B | |
-1.73% | 11.77B |